Your session is about to expire
← Back to Search
CADENCE Program for Opioid Use Disorder in Pregnancy (CADENCE Trial)
CADENCE Trial Summary
This trial seeks to improve outcomes for mothers and babies affected by opioid use disorders. It will examine data and programs to better understand and support these families.
CADENCE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCADENCE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.CADENCE Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am over 18, pregnant, and have an opioid use disorder.I am under 18 years old.
- Group 1: CADENCE program pilot
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are participants currently being sought for this clinical experiment?
"Clinicaltrials.gov has confirmed that this study, which was initially published on October 1st 2023 and most recently revised on November 2nd 2022, is no longer recruiting participants. However, there are 420 other trials accepting new volunteers at the moment."
What benchmarks is this clinical trial looking to achieve?
"The primary goal of this research, measured at the time of delivery hospitalization, is to reduce pharmacologically treated neonatal outcomes. Additionally, it seeks to evaluate prenatal care adequacy via a Kotelchuck index score as well as first trimester entry into such services and total length of stay for newborns during their admission period."
Share this study with friends
Copy Link
Messenger